Moderna’s top doc: No data supports halving COVID vaccine doses

by on

Moderna’s leaders discussed the company’s COVID-19 vaccine at the J.P. Morgan Healthcare Conference, including whether doses can be halved in order to administer them to more people.

Moderna’s leaders discussed the company’s COVID-19 vaccine at the J.P. Morgan Healthcare Conference, including whether doses can be halved in order to administer them to more people.

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: